SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 154 filers reported holding SCICLONE PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,432,000 | +113.4% | 127,873 | +86.7% | 0.22% | +93.7% |
| Q1 2017 | $671,000 | +4.2% | 68,473 | +14.8% | 0.11% | +15.6% |
| Q4 2016 | $644,000 | +332.2% | 59,663 | +309.1% | 0.10% | +357.1% |
| Q3 2016 | $149,000 | -22.4% | 14,585 | -16.5% | 0.02% | -32.3% |
| Q1 2016 | $192,000 | – | 17,463 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athos Capital Ltd | 284,200 | $3,126,000 | 1.80% |
| Nine Chapters Capital Management LLC | 13,600 | $150,000 | 1.42% |
| Stonepine Capital Management, LLC | 216,307 | $2,379,000 | 1.28% |
| GLG Partners LP | 1,588,897 | $17,478,000 | 0.97% |
| MENTA CAPITAL LLC | 431,996 | $4,752,000 | 0.56% |
| Sapphire Star Partners LP | 24,834 | $273,000 | 0.34% |
| Yakira Capital Management, Inc. | 85,500 | $941,000 | 0.28% |
| TFS CAPITAL LLC | 55,104 | $606,000 | 0.24% |
| BRANT POINT INVESTMENT MANAGEMENT LLC | 100,000 | $1,100,000 | 0.13% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 102,261 | $1,125,000 | 0.12% |